FULL DETAILS (Read-only)  -> Click Here to Create PDF for Current Dataset of Trial
CTRI Number  CTRI/2026/02/104599 [Registered on: 24/02/2026] Trial Registered Prospectively
Last Modified On: 23/02/2026
Post Graduate Thesis  Yes 
Type of Trial  Interventional 
Type of Study   Drug
Surgical/Anesthesia 
Study Design  Randomized, Parallel Group, Active Controlled Trial 
Public Title of Study   Comparison of Retrolaminar block and Local anaesthetic infiltration for post operative pain relief in patients undergoing spine surgery 
Scientific Title of Study   Comparison of postoperative analgesic efficacy between bilateral ultrasound guided Retrolaminar block and local anaesthetic infiltration in patients undergoing Thoraco-lumbar spine surgery – a double blinded prospective randomized controlled trial 
Trial Acronym  Nil 
Secondary IDs if Any  
Secondary ID  Identifier 
NIL  NIL 
 
Details of Principal Investigator or overall Trial Coordinator (multi-center study)  
Name  Dr Saurabh Mishra 
Designation  Junior resident 
Affiliation  Institute of Medical science, Banaras Hindu University 
Address  Department of Anaesthesiology, Institute of Medical sciences, Banaras Hindu University, Varanasi

Varanasi
UTTAR PRADESH
221005
India 
Phone  7427057781  
Fax    
Email  saurabh.mukeshmishra2000@gmail.com  
 
Details of Contact Person
Scientific Query
 
Name  Dr Reena 
Designation  Associate Professor 
Affiliation  Institute of Medical science, Banaras Hindu University 
Address  Department of Anaesthesiology, Institute of Medical sciences, Banaras Hindu University, Varanasi

Varanasi
UTTAR PRADESH
221005
India 
Phone  9628679954  
Fax    
Email  reena@bhu.ac.in  
 
Details of Contact Person
Public Query
 
Name  Dr Reena 
Designation  Associate Professor 
Affiliation  Institute of Medical science, Banaras Hindu University 
Address  Department of Anaesthesiology, Institute of Medical sciences, Banaras Hindu University, Varanasi

Varanasi
UTTAR PRADESH
221005
India 
Phone  9628679954  
Fax    
Email  reena@bhu.ac.in  
 
Source of Monetary or Material Support  
NIL 
 
Primary Sponsor  
Name  Sir Sunderlal Hospital IMS BHU 
Address  Institute Of Medical Sciences, Banaras Hindu University, Varanasi, 221005, Uttar Pradesh, India 
Type of Sponsor  Government medical college 
 
Details of Secondary Sponsor  
Name  Address 
Nil  Nil 
 
Countries of Recruitment     India  
Sites of Study  
No of Sites = 2  
Name of Principal Investigator  Name of Site  Site Address  Phone/Fax/Email 
Dr Saurabh Mishra  Department of Neurosurgery  Trauma Center and Super Speciality Hospital, Institute of Medical Sciences, Banaras Hindu University
Varanasi
UTTAR PRADESH 
7427057781

saurabh.mukeshmishra2000@gmail.com 
Dr Saurabh Mishra  Department of Orthopaedics  Trauma Center and Super speciality Hospital, Institute Of Medical Sciences, Banaras Hindu University
Varanasi
UTTAR PRADESH 
7427057781

saurabh.mukeshmishra2000@gmail.com 
 
Details of Ethics Committee  
No of Ethics Committees= 1  
Name of Committee  Approval Status 
Institutional ethics commiittee, Institute of Medical sciences, Banaras Hindu University  Approved 
 
Regulatory Clearance Status from DCGI  
Status 
Not Applicable 
 
Health Condition / Problems Studied  
Health Type  Condition 
Patients  (1) ICD-10 Condition: M968||Other intraoperative and postprocedural complications and disorders of musculoskeletal system, not elsewhere classified,  
 
Intervention / Comparator Agent  
Type  Name  Details 
Comparator Agent  Local Anaesthetic Infiltration  Group L: Wound infiltration at the end of surgery using 40ml 0.2% Ropivacaine 
Intervention  Retrolaminar Block  Group R: Bilateral Ultrasound guided Retrolaminar Block with 20 ml 0.2% Ropivacaine given after induction of general anaesthesia, before skin incision. Duration of block will be measured from placement of ultrasound probe on the skin to complete instillation of 20 ml drug on either side. 
 
Inclusion Criteria  
Age From  18.00 Year(s)
Age To  65.00 Year(s)
Gender  Both 
Details  1. Patients (age 18 to 65 years) with ASA grade I-III undergoing Thoraco-lumbar spine surgery
under general anaesthesia
2. Patients who can understand and provide a valid consent for the procedure and can
understand and are willing to report the pain using NRS score. 
 
ExclusionCriteria 
Details  1. Patients not giving consent
2. Duration of surgery more than 3 hours
3. Patients with allergies to local anaesthetics
4. Bleeding disorders
5. Anti-coagulant or anti-platelet drugs, INR more than 1.5
6. Localised infections
7. Patients in whom the sono-anatomy of the anaesthetic injection site is not clearly
delineable due to any reason
8. Patients with associated Rib fracture and polytrauma patient with associated head, thoracic,
abdominal injury
9. Patients with previous history of spine surgery 
 
Method of Generating Random Sequence   Computer generated randomization 
Method of Concealment   Sequentially numbered, sealed, opaque envelopes 
Blinding/Masking   Participant and Investigator Blinded 
Primary Outcome  
Outcome  TimePoints 
To compare the post operative analgesic efficacy assessed by Numeric Rating Scale(NRS),
between Bilateral USG guided Retrolaminar Block and local anaesthetic infiltration in
patients undergoing thoraco-lumbar spine surgery. 
30 min, 1 hour, 2 hour, 6 hour, 12 hour, 24 hour 
 
Secondary Outcome  
Outcome  TimePoints 
To compare the time to first dose of rescue analgesia intravenous injection (drug
TRAMADOL 1mg/kg) required to achieve adequate analgesia (Numeric Rating Scale less than and equal to 3)
between two groups. 
30 min, 1 hour, 2 hour, 6 hour, 12 hour, 24 hour 
To compare the total dose (in mg) of rescue analgesia intravenous injection (drug
TRAMADOL 1mg/kg) required to achieve adequate analgesia (Numeric Rating Scale less than and equal to 3) in the first 24 hours post surgery between two groups. 
30 min, 1 hour, 2 hour, 6 hour, 12 hour, 24 hour 
To compare Intraoperative intravenous FENTANYL consumption (0.5mcg/kg intravenous dose given when MAP or HR more than 20% of preoperative values)  Duration of surgery 
To compare Total duration of hospital stay  Duration of hospital stay 
 
Target Sample Size   Total Sample Size="68"
Sample Size from India="68" 
Final Enrollment numbers achieved (Total)= "Applicable only for Completed/Terminated trials"
Final Enrollment numbers achieved (India)="Applicable only for Completed/Terminated trials" 
Phase of Trial   N/A 
Date of First Enrollment (India)   08/03/2026 
Date of Study Completion (India) Applicable only for Completed/Terminated trials 
Date of First Enrollment (Global)  Date Missing 
Date of Study Completion (Global) Applicable only for Completed/Terminated trials 
Estimated Duration of Trial   Years="1"
Months="0"
Days="0" 
Recruitment Status of Trial (Global)   Not Yet Recruiting 
Recruitment Status of Trial (India)  Not Yet Recruiting 
Publication Details   N/A 
Individual Participant Data (IPD) Sharing Statement

Will individual participant data (IPD) be shared publicly (including data dictionaries)?  

Response - NO
Brief Summary  
The study will be conducted in Trama Emergency OT, Orthopaedics Elective OT and Neurosurgery Elective OT in Trauma Centre, Institute of Medical Sciences, BHU, Varanasi. After approval from hospital research and ethical committee, a double blinded prospective Randomized study will be conducted on patients coming to IMS, BHU, Varanasi. Once the patients are enrolled, they will be randomized into either Group R or Group L. Randomization will be done using computer generated random number sequence. Allocation concealment will be done using serially numbered opaque sealed envelopes. The process of allocation will be done by a staff member who is not a part of the study group. There will be 68 such sealed opaque envelopes pre-designed with equal numbers of Retrolaminar block and local anaesthetic infiltration. One day prior to the scheduled surgery, all the patients will be instructed on how to evaluate their own pain by using a 10cm Numeric rating pain scale( 0-no pain, 10-maximum pain). In the
operating room after attaching the standard ASA monitors and IV lines, the patient will be induced using standardized general anaesthesia protocol as routinely followed in our department. IV induction along with muscle relaxation followed by endotracheal intubation will be done using appropriate size cuffed tube. Mechanical Ventilation will be established with an oxygen-air mixture and titrated to ETCO2 between 35 to 45 mm Hg. Analgesia maintained with Inj. Fentanyl 2mcg/kg at induction given for all patients. Maintenance of anaesthesia will be done using inhalation agent Isoflurane and intermittent muscle relaxant as required. Fluid therapy will be provided according to routine institutional practice. Inj. Dexamethasone 0.1mg/kg IV will be given to all patients at the start of surgery. Inj. Diclofenac 75 mg iv will be given to all patients prior to skin incisions. If MAP or HR is more than equal to 20% from baseline, ruling out hemodynamic causes or insufficient depth of anaesthesia, Inj. Fentanyl 0.5 mcg/kg will be given for intraoperative pain management. Patients will be turned to prone position taking care of endotracheal tube, pressure points, eye, spine and possible nerve injuries.
Group R (Retrolaminar Group): Before the incision, the intervention area will be sterilized with povidone iodine and spirit before the procedure, covered by sterile drapes and a sterile sheath will be applied to the ultrasound probe. High frequency linear or curved array probe is selected depending on the patient’s body habitus and depth of the vertebral lamina. The ultrasound probe will be placed sagittally in the midline at the target vertebral level, i.e., intermediate one for surgical level(s) of odd number or the upper or second one for surgical levels of even number. After the spinous processes are seen, the ultrasound probe is moved laterally 1-2 cm and vertebral lamina are observed. A 5-10 cm 22G stimuplex needle is inserted in real time in cranial to caudal direction with in plane technique. When the needle touches the lamina, Inj. Ropivacaine 0.2% 20ml is administered with low pressure. The same intervention will be performed on the other side of the vertebral lamina.
Group L (Local anaesthetic infiltration group): Wound infiltration will be performed by the surgeon at the end of the surgery. After hemostasis achieved and before skin closure, 40 mL of 0.20% ropivacaine will be infiltrated into multiple layers of the surgical wound, in prone position. This will include the subcutaneous tissue and muscle layers, ensuring the even distribution of the anesthetic solution to cover the entire surgical area. Inj. Paracetamol 1 gm iv will be given to all patients 15 min, before skin closure. At the end of surgery, Inj. Ondansetron 0.1mg/kg will be given and muscle relaxation will be reversed with Inj. Neostigmine 50 mcg/kg and Inj. Glycopyrrolate 10mcg/kg. The patient will be extubated and the patients will be transferred to Post-Anaesthesia care unit.
Once the patients are transferred into wards, all will receive round the clock Inj. Paracetamol 1 gm IV 8 hourly and Inj. Diclofenac 75 mg 12 hourly. For rescue analgesia (when the NRS score will be more than 3) in postoperative period, Inj. Tramadol 1mg/kg will be given. The duration of analgesia will be from administration of block to the first use of rescue analgesia. Total consumption of Inj. Tramadol as rescue analgesic will be recorded in the 24 hour observation period. Incidence of Side Effects: nausea, vomiting and surgical site infection will be recorded as binary outcomes (present/absent). The total length of hospital stay will also be recorded (starting from the day of surgery which will be taken as Day 0).
 
Close